We are live on ! Find out more
NTC

NF Trinity Capital Portfolio holdings

AUM $626M
1-Year Est. Return 3.16%
This Fund
S&P 500
This Quarter Est. Return
-18.19%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$615M
AUM Growth
-$141M
Cap. Flow
-$7.38M
Cap. Flow %
-1.2%
Top 10 Hldgs %
65.48%
Holding
57
New
1
Increased
13
Reduced
3
Closed
7

Top Buys

1
META icon
Meta Platforms (Facebook)
META
+$13.4M
2
BIDU icon
Baidu
BIDU
+$8.95M
3
BABA icon
Alibaba
BABA
+$6.22M
4
ON icon
ON Semiconductor
ON
+$4.81M
5
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$4.33M

Top Sells

1
APTX
Aptinyx Inc. Common Stock
APTX
+$17.6M
2
TMO icon
Thermo Fisher Scientific
TMO
+$10.3M
3
UBX
Unity Biotechnology
UBX
+$9.9M
4
CRM icon
Salesforce
CRM
+$5.14M
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$5.02M

Sector Composition

1 Communication Services 30.78%
2 Consumer Discretionary 25.29%
3 Technology 13.22%
4 Financials 12.6%
5 Healthcare 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAL icon
26
TAL Education Group
TAL
$5.68B
$6.1M 0.99%
228,791
– –
ALXN
27
DELISTED
Alexion Pharmaceuticals
ALXN
$6.08M 0.99%
62,500
– –
OPTU
28
Optimum Communications Inc
OPTU
$337M
$5.6M 0.91%
339,042
– –
GILD icon
29
Gilead Sciences
GILD
$167B
$5.44M 0.88%
86,959
– –
BMY icon
30
Bristol-Myers Squibb
BMY
$124B
$4.83M 0.79%
93,000
– –
APLS
31
DELISTED
Apellis Pharmaceuticals
APLS
$4.71M 0.77%
357,142
– –
DB icon
32
Deutsche Bank
DB
$67.3B
$4.26M 0.69%
533,225
– –
PM icon
33
Philip Morris
PM
$301B
$4.21M 0.68%
63,000
– –
IBB icon
34
iShares Biotechnology ETF
IBB
$9.23B
$4.17M 0.68%
43,200
– –
CRM icon
35
Salesforce
CRM
$140B
$3.85M 0.63%
28,088
-37,362
-57% -$5.14M
SAGE
36
DELISTED
Sage Therapeutics
SAGE
$3.11M 0.51%
32,506
– –
VTRS icon
37
Viatris
VTRS
$20.1B
$2.74M 0.45%
100,000
– –
IOVA icon
38
Iovance Biotherapeutics
IOVA
$2.23B
$2.02M 0.33%
228,442
+103,588
+83% +$999K
SLB icon
39
SLB Ltd
SLB
$70.3B
$2M 0.33%
55,500
– –
INCY icon
40
Incyte
INCY
$23.4B
$1.97M 0.32%
31,000
– –
HIMX
41
Himax Technologies
HIMX
$2.23B
$1.61M 0.26%
470,000
– –
MNK
42
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.61M 0.26%
102,000
– –
VKTX icon
43
Viking Therapeutics
VKTX
$4.31B
$1.07M 0.17%
+140,000
New +$1.67M
TEVA icon
44
Teva Pharmaceuticals
TEVA
$37.3B
$817K 0.13%
53,000
– –
FLNT
45
Fluent
FLNT
$111M
$701K 0.11%
32,467
– –
XLRN
46
DELISTED
Acceleron Pharma
XLRN
$626K 0.1%
14,369
– –
GS icon
47
Goldman Sachs
GS
$314B
$618K 0.1%
3,700
– –
VIPS icon
48
Vipshop
VIPS
$6.96B
$287K 0.05%
52,644
– –
ARAV
49
DELISTED
Aravive, Inc. Common Stock
ARAV
$144K 0.02%
40,816
– –
DNLI icon
50
Denali Therapeutics
DNLI
$3.7B
– –
-112,273
Closed -$2.44M
1
2
3

Similar funds

SGAM
Steinberg Global Asset Management Boca Raton, Florida $639M AUM 11.04% 1-Year Est. Return
ACM
Aviance Capital Management Sarasota, Florida $668M AUM 6.48% 1-Year Est. Return
TL
Tirschwell & Loewy New York $731M AUM 15.44% 1-Year Est. Return
DSI
Daiwa SB Investments Tokyo, Japan $506M AUM 11% 1-Year Est. Return
SCA
Secor Capital Advisors New York $485M AUM 3.33% 1-Year Est. Return
SHCM
Stokes & Hubbell Capital Management New Orleans, Louisiana $476M AUM 5.4% 1-Year Est. Return
IAS
INR Advisory Services Media, Pennsylvania $786M AUM 2.23% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return

NF Trinity Capital's Q4 2018 Portfolio in Review

As of Q4 2018, NF Trinity Capital held 57 positions worth $615M, down 19% from $757M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

NF Trinity Capital's Q4 2018 filing shows 1 new, 13 increased, 3 reduced and 7 closed positions. Its largest new stake was Viking Therapeutics: 140,000 shares worth $1.07M. The largest sale was Aptinyx Inc. Common Stock, an estimated $17.6M.

By sector, the portfolio is most concentrated in Communication Services at 31% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Technology.

  • NF Trinity Capital's largest Q4 2018 buy was Viking Therapeutics: 140,000 shares worth $1.07M.
  • NF Trinity Capital added most to Meta Platforms (Facebook) in Q4 2018, an estimated $13.4M increase.
  • NF Trinity Capital's biggest Q4 2018 reduction was Salesforce, cutting an estimated $5.14M.
  • NF Trinity Capital fully exited Aptinyx Inc. Common Stock in Q4 2018, selling an estimated $17.6M.
  • NF Trinity Capital's ten largest holdings make up 65% of its $615M portfolio in Q4 2018.
  • NF Trinity Capital opened 1 new position and closed 7 in Q4 2018.
  • NF Trinity Capital's portfolio value fell 19% quarter-over-quarter to $615M.

Based on NF Trinity Capital's 13F filing for Q4 2018, filed 31 Jan 2019.